| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.008 | 1 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.00089 | 1 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |